Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Insulin API Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Insulin API Market Status and Forecast (2016-2027)
      • 1.3.2 Global Insulin API Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Insulin API Supply by Company

    • 2.1 Global Insulin API Sales Volume by Company
    • 2.2 Global Insulin API Sales Value by Company
    • 2.3 Global Insulin API Price by Company
    • 2.4 Insulin API Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Insulin API Market Status by Category

    • 3.1 Insulin API Category Introduction
      • 3.1.1 Regular Human Insulin
      • 3.1.2 Insulin Analogue
    • 3.2 Global Insulin API Market by Category
      • 3.2.1 Global Insulin API Sales Volume by Category (2016-2021)
      • 3.2.2 Global Insulin API Sales Value by Category (2016-2021)
      • 3.2.3 Global Insulin API Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Insulin API Market Status by End User/Segment

    • 4.1 Insulin API Segment by End User/Segment
      • 4.1.1 Fast-Acting
      • 4.1.2 Premix
      • 4.1.3 Long-Acting
    • 4.2 Global Insulin API Market by End User/Segment
      • 4.2.1 Global Insulin API Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Insulin API Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Insulin API Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Insulin API Market Status by Region

    • 5.1 Global Insulin API Market by Region
      • 5.1.1 Global Insulin API Sales Volume by Region
      • 5.1.2 Global Insulin API Sales Value by Region
    • 5.2 North America Insulin API Market Status
    • 5.3 Europe Insulin API Market Status
    • 5.4 Asia Pacific Insulin API Market Status
    • 5.5 Central & South America Insulin API Market Status
    • 5.6 Middle East & Africa Insulin API Market Status

    6 North America Insulin API Market Status

    • 6.1 North America Insulin API Market by Country
      • 6.1.1 North America Insulin API Sales Volume by Country (2016-2021)
      • 6.1.2 North America Insulin API Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Insulin API Market Status

    • 7.1 Europe Insulin API Market by Country
      • 7.1.1 Europe Insulin API Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Insulin API Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Insulin API Market Status

    • 8.1 Asia Pacific Insulin API Market by Country
      • 8.1.1 Asia Pacific Insulin API Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Insulin API Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Insulin API Market Status

    • 9.1 Central & South America Insulin API Market by Country
      • 9.1.1 Central & South America Insulin API Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Insulin API Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Insulin API Market Status

    • 10.1 Middle East & Africa Insulin API Market by Country
      • 10.1.1 Middle East & Africa Insulin API Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Insulin API Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Insulin API Distributors
    • 11.3 Insulin API Buyers

    12 Global Insulin API Market Forecast by Category and by End User/Segment

    • 12.1 Global Insulin API Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Insulin API Forecast by Category
      • 12.2.1 Global Insulin API Sales Volume Forecast by Category
      • 12.2.2 Global Insulin API Sales Value Forecast by Category
      • 12.2.3 Global Insulin API Price Forecast by Category
    • 12.3 Global Insulin API Forecast by End User/Segment
      • 12.3.1 Global Insulin API Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Insulin API Sales Value Forecast by End User/Segment
      • 12.3.3 Global Insulin API Price Forecast by End User/Segment

    13 Global Insulin API Market Forecast by Region/Country

    • 13.1 Global Insulin API Market Forecast by Region (2022-2027)
      • 13.1.1 Global Insulin API Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Insulin API Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Novo Nordisk
      • 14.1.1 Company Information
      • 14.1.2 Insulin API Product Introduction
      • 14.1.3 Novo Nordisk Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Sanofi-Aventis
      • 14.2.1 Company Information
      • 14.2.2 Insulin API Product Introduction
      • 14.2.3 Sanofi-Aventis Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Wockhardt
      • 14.3.1 Company Information
      • 14.3.2 Insulin API Product Introduction
      • 14.3.3 Wockhardt Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Julphar Diabetes
      • 14.4.1 Company Information
      • 14.4.2 Insulin API Product Introduction
      • 14.4.3 Julphar Diabetes Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Torrent Pharma
      • 14.5.1 Company Information
      • 14.5.2 Insulin API Product Introduction
      • 14.5.3 Torrent Pharma Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Tonghua Dongbao
      • 14.6.1 Company Information
      • 14.6.2 Insulin API Product Introduction
      • 14.6.3 Tonghua Dongbao Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 United Laboratory
      • 14.7.1 Company Information
      • 14.7.2 Insulin API Product Introduction
      • 14.7.3 United Laboratory Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Amphastar
      • 14.8.1 Company Information
      • 14.8.2 Insulin API Product Introduction
      • 14.8.3 Amphastar Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Eli Lilly
      • 14.9.1 Company Information
      • 14.9.2 Insulin API Product Introduction
      • 14.9.3 Eli Lilly Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Ganlee
      • 14.10.1 Company Information
      • 14.10.2 Insulin API Product Introduction
      • 14.10.3 Ganlee Insulin API Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Biocon

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Insulin API market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Insulin API market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Regular Human Insulin
    Insulin Analogue

    Segmented by End User/Segment
    Fast-Acting
    Premix
    Long-Acting

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Novo Nordisk
    Sanofi-Aventis
    Wockhardt
    Julphar Diabetes
    Torrent Pharma
    Tonghua Dongbao
    United Laboratory
    Amphastar
    Eli Lilly
    Ganlee
    Biocon
    Buy now